577 related articles for article (PubMed ID: 32896807)
1. Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives.
Ammar YA; Farag AA; Ali AM; Ragab A; Askar AA; Elsisi DM; Belal A
Bioorg Chem; 2020 Nov; 104():104164. PubMed ID: 32896807
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies.
Ammar YA; Farag AA; Ali AM; Hessein SA; Askar AA; Fayed EA; Elsisi DM; Ragab A
Bioorg Chem; 2020 Jun; 99():103841. PubMed ID: 32325335
[TBL] [Abstract][Full Text] [Related]
3. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
Salem MA; Ragab A; Askar AA; El-Khalafawy A; Makhlouf AH
Eur J Med Chem; 2020 Feb; 188():111977. PubMed ID: 31927313
[TBL] [Abstract][Full Text] [Related]
4. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, Antimicrobial and Anti-biofilm Evaluation, and Molecular Docking of Newly Substituted Fluoroquinazolinones.
Zayed MF; Ibrahim SRM; Habib EE; Hassan MH; Ahmed S; Rateb HS
Med Chem; 2019; 15(6):659-675. PubMed ID: 30411687
[TBL] [Abstract][Full Text] [Related]
6. Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents.
Akhavan M; Foroughifar N; Pasdar H; Bekhradnia A
Comb Chem High Throughput Screen; 2019; 22(10):716-727. PubMed ID: 31775594
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
[TBL] [Abstract][Full Text] [Related]
8. New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking.
Merlani M; Barbakadze V; Amiranashvili L; Gogilashvili L; Poroikov V; Petrou A; Geronikaki A; Ciric A; Glamoclija J; Sokovic M
Curr Top Med Chem; 2019; 19(4):292-304. PubMed ID: 30674263
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis, biological evaluation of bis-(1,2,3- and 1,2,4)-triazole derivatives as potential antimicrobial and antifungal agents.
Bitla S; Gayatri AA; Puchakayala MR; Kumar Bhukya V; Vannada J; Dhanavath R; Kuthati B; Kothula D; Sagurthi SR; Atcha KR
Bioorg Med Chem Lett; 2021 Jun; 41():128004. PubMed ID: 33811989
[TBL] [Abstract][Full Text] [Related]
10. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA.
Ibrahim SA; Fayed EA; Rizk HF; Desouky SE; Ragab A
Bioorg Chem; 2021 Nov; 116():105339. PubMed ID: 34530234
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial activity of 2,3-bis(bromomethyl)quinoxaline derivatives.
Ishikawa H; Sugiyama T; Kurita K; Yokoyama A
Bioorg Chem; 2012; 41-42():1-5. PubMed ID: 22245018
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents.
Mekonnen Sanka B; Mamo Tadesse D; Teju Bedada E; Mengesha ET; Babu G N
Bioorg Chem; 2022 Feb; 119():105568. PubMed ID: 34968884
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,3-bis(halomethyl)quinoxaline derivatives and evaluation of their antibacterial and antifungal activities.
Ishikawa H; Sugiyama T; Yokoyama A
Chem Pharm Bull (Tokyo); 2013; 61(4):438-44. PubMed ID: 23546003
[TBL] [Abstract][Full Text] [Related]
14. Substituted 6,7-dimethoxy-5-oxo-2,3,5,9b-tetrahydrothiazolo[2,3-a]isoindole- 3-1,1-dioxide Derivatives with Antimicrobial Activity and Docking Assisted Prediction of the Mechanism of their Antibacterial and Antifungal Properties.
Geronikaki A; Kartsev V; Eleftheriou P; Petrou A; Glamočlija J; Ciric A; Soković M
Curr Top Med Chem; 2020; 20(29):2681-2691. PubMed ID: 32962619
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.
Tandon VK; Yadav DB; Maurya HK; Chaturvedi AK; Shukla PK
Bioorg Med Chem; 2006 Sep; 14(17):6120-6. PubMed ID: 16806945
[TBL] [Abstract][Full Text] [Related]
16. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
17. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
18. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase.
Fouda AM; Hassan AH; Eliwa EM; Ahmed HEA; Al-Dies AM; Omar AM; Nassar HS; Halawa AH; Aljuhani N; El-Agrody AM
Bioorg Chem; 2020 Dec; 105():104387. PubMed ID: 33130344
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme.
El-Attar MAZ; Elbayaa RY; Shaaban OG; Habib NS; Abdel Wahab AE; Abdelwahab IA; El-Hawash SAM
Bioorg Chem; 2018 Feb; 76():437-448. PubMed ID: 29275262
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents.
Türe A; Kulabaş N; Dingiş Sİ; Birgül K; Bozdeveci A; Alpay Karaoğlu Ş; Krishna VS; Sriram D; Küçükgüzel İ
Bioorg Chem; 2019 Jul; 88():102965. PubMed ID: 31085371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]